Immunohistochemical staining of hepatocellular carcinoma with monoclonal antibody against inhibin

被引:31
作者
McCluggage, WG [1 ]
Maxwell, P [1 ]
Patterson, A [1 ]
Sloan, JM [1 ]
机构
[1] QUEENS UNIV BELFAST, BELFAST, ANTRIM, NORTH IRELAND
关键词
alpha-fetoprotein; hepatocellular carcinoma; immunohistochemistry; inhibin; liver;
D O I
10.1046/j.1365-2559.1997.5580774.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Inhibin is a peptide hormone produced by ovarian granulosa cells. During a recent study investigating the immunohistochemical staining of ovarian granulosa cell tumours and other neoplasms with an anti-inhibin monoclonal antibody, we identified strong cytoplasmic staining of hepatocytes. In the present study we investigated the immunostaining of hepatocellular carcinoma and other neoplasms involving the liver with anti-inhibin to determine whether the antibody may be of value in the differential diagnosis of hepatic neoplasms, Immunostaining for alpha-fetoprotein was also performed, With anti-inhibin there was positive, generally strong, cytoplasmic staining of 17 of 19 cases of hepatocellular carcinoma, including the pleomorphic and glandular variants, There was positive staining of six of 20 cases of adenocarcinoma, In these, positive staining was generally focal, of weal; intensity and involved the luminal surface of neoplastic glands, There was no staining of five cases of neuroendocrine tumour, There was positive staining for alpha-fetoprotein in 13 of 19 cases of hepatocellular carcinoma and in two of 20 cases of adenocarcinoma but no staining of neuroendocrine tumours, Immunostaining with anti-inhibin antibody may be of value in the differentiation of hepatocellular carcinoma from other neoplasms involving the liver, The antibody is a more sensitive, but less specific, immunohistochemical marker for hepatocellular carcinoma than is alpha-fetoprotein.
引用
收藏
页码:518 / 522
页数:5
相关论文
共 24 条
[1]   THE SIGNIFICANCE OF ALPHA-FETOPROTEIN AND OTHER TUMOR-MARKERS IN DIFFERENTIAL IMMUNOCYTOCHEMISTRY OF PRIMARY LIVER-TUMORS [J].
BRUMM, C ;
SCHULZE, C ;
CHARELS, K ;
MOROHOSHI, T ;
KLOPPEL, G .
HISTOPATHOLOGY, 1989, 14 (05) :503-513
[2]  
CHRISTENSEN WN, 1989, MODERN PATHOL, V2, P8
[3]   INHIBIN AS A MARKER FOR OVARIAN-CANCER [J].
COOKE, I ;
OBRIEN, M ;
CHARNOCK, FM ;
GROOME, N ;
GANESAN, TS .
BRITISH JOURNAL OF CANCER, 1995, 71 (05) :1046-1050
[4]   IMMUNOHISTOCHEMICAL CHARACTERIZATION OF 130 CASES OF PRIMARY HEPATIC CARCINOMAS [J].
FERRANDEZIZQUIERDO, A ;
LLOMBARTBOSCH, A .
PATHOLOGY RESEARCH AND PRACTICE, 1987, 182 (06) :783-791
[5]  
FISCHER HP, 1987, AM J PATHOL, V127, P530
[6]  
GANJEI P, 1988, CANCER-AM CANCER SOC, V62, P1994, DOI 10.1002/1097-0142(19881101)62:9<1994::AID-CNCR2820620920>3.0.CO
[7]  
2-0
[8]  
GOODMAN ZD, 1985, CANCER-AM CANCER SOC, V55, P124, DOI 10.1002/1097-0142(19850101)55:1<124::AID-CNCR2820550120>3.0.CO
[9]  
2-Z
[10]  
HIROHASHI S, 1983, JPN J CLIN ONCOL, V13, P37